EP4651915A1 - Hydrogels and uses thereof - Google Patents
Hydrogels and uses thereofInfo
- Publication number
- EP4651915A1 EP4651915A1 EP24702207.2A EP24702207A EP4651915A1 EP 4651915 A1 EP4651915 A1 EP 4651915A1 EP 24702207 A EP24702207 A EP 24702207A EP 4651915 A1 EP4651915 A1 EP 4651915A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- cnf
- cnc
- hydrogel
- acrylamide
- ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3808—Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3821—Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Definitions
- the invention generally contemplates hydrogel materials, devices and products implementing same.
- Hydrogels are highly absorbent, three-dimensional hydrophilic crosslinked polymer networks. Hydrogels have been proposed as potential candidates for many different applications and fields, ranging from artificial muscles, vertebral disk replacements, absorbents, and electroconductive materials. However, many hydrogels exhibit poor mechanical properties, reflected in low extensibility, brittleness, low resilience, irreversible deformation, and lack of biocompatibility, which limit their applications. Many approaches have been attempted to endow hydrogels with these properties. Some of these approaches include utilizing topological polymers, nanocomposites, microgels and double network-based reinforcements.
- Nanomaterials such as carbon nanotubes (CNTs), silica, clay and other inorganic particles have been employed, producing some encouraging results, though mostly at a cost of reduced biocompatibility and potential cytotoxicity.
- CNTs carbon nanotubes
- silica silica
- clay and other inorganic particles have been employed, producing some encouraging results, though mostly at a cost of reduced biocompatibility and potential cytotoxicity.
- Cellulose is the most abundant biopolymer on earth, and usually functions as a load-bearing component in plants’ cell walls, imparting the cell wall with mechanical strength and robustness.
- the main sources of cellulose are plants and plant-based waste such as paper, cotton, cardboard, and agricultural waste. In some cases, it can also be produced by bacteria or animals such as tunicates.
- Cellulose is composed of linear chains of 1-4 D-glucose, arranged in an ordered fibril structure, which is comprised of ordered crystalline regions linked together by less ordered amorphous areas.
- Cellulose may be degraded using mechanical shearing methods to Cellulose nano Fibers (CNF), which are comprised of both the crystalline and amorphous regions of the fiber, resulting in particles which are 10-40nm in width and span several microns in length. Further degradation, usually by acid hydrolysis, leads to extraction of the crystalline regions alone, known as Cellulose Nano Crystals (CNC).
- CNCs are 5-10nm in width and a few micrometers in length, depending on the cellulose source. CNC displays amazing mechanical properties, akin to materials such as carbon fibers and Kevlar, with single fibers displaying a Young’s modulus of 150GPa and tensile strength of 7.5GPa.
- a graft copolymer broadly consists of a backbone polymer (main chain) from which one or more monomers of a different polymer branch out, forming long polymeric chains (grafts), and may enable the combination of the leading properties of the materials used in one physical unit.
- grafting techniques may be divided into three approaches, which may be used individually or combined: First, “grafting to” in which the end of a pre-formed polymer is coupled to the functional groups of the backbone polymer. Second, “grafting from” in which the propagation of the grafted polymer chains occurs from initiating sites on the backbone polymer. Third, “grafting through” in which the macromonomer of backbone and grafted polymer are copolymerized using a co-monomer, usually by radical polymerization.
- the radicals formed can initiate the graft polymerization of vinyl and acryl monomers.
- acrylic monomers such as acrylamide (AM) may also readily polymerize by radical methods, yielding a graft polymerization system of covalently-bound cellulose-acrylamide complexes, from which long polyacrylamide (PAAM) chains begin propagating from the particle’s surface, utilizing the principles of both the “grafting from” and “grafting through” approaches.
- Cellulose-based materials have been proposed as reinforcing agents for various nanocomposites. Despite a wide range of compositions, forms and chemistries, many of the reported hydrogel systems suffer from a lack of sufficient mechanical strength and biocompatibility. Fibrillar cellulose-based materials have been proposed as reinforcing agents that may aid in overcoming these challenges. Unlike hydrogel systems reported, and other systems reinforced with cellulose-based materials, a composite of polyacrylamide reinforced with modified cellulose-derived nanofibers, namely cellulose nano crystals (CNC) and cellulose nano fibers (CNF), exhibited superior biocompatibility and mechanical properties. While CNC and CNF display different and sometimes opposing properties, by introducing mixtures of differing material ratios, composites of superior mechanical and rheological properties may be manufactured, opening the door for a greater gamut of uses and fabrication technologies.
- CNC cellulose nano crystals
- CNF cellulose nano fibers
- hydrogels of the invention have proven biocompatible when seeded with GFP-transfected mouse fibroblasts (3T3s), showing a significant increase in cell viability and proliferation as compared to samples comprised of polyacrylamide alone.
- Hydrogels of the invention have been manufactured by a metal-initiated, e.g., cerium-initiated graft polymerization of CNC and CNF to a polyacrylamide matrix. Propagation of acrylamide chains grafted on cellulose-derived nanoparticle’s surface is then initiated by radical polymerization and heat resulting in the polyacrylamide matrix depicted in Fig. 1.
- the long polymer chains were further crosslinked e.g., by adding N,N’ -methylene bisacrylamide (MBA) to form a uniform chemical network of long flexible chains interconnected by homogeneously dispersed cellulose-derived nanomaterials (e.g., in a form of nanoparticles).
- MSA N,N’ -methylene bisacrylamide
- These nanomaterials act both as multifunctional crosslinkers and as reinforcing agents- resulting in highly extendable, resilient soft polymer hydrogels.
- a material comprising or consisting of a cellulose nanomaterial grafted with acrylamide, wherein the cellulose material consisting a mixture of both cellulose nano crystals (CNC) and cellulose nano fibers (CNF).
- the invention further provides a matrix material comprising or consisting of a polymeric material comprising units of acrylamide, CNC and CNF, wherein said units are polymerized therebetween to provide the matrix material.
- a material derived or formed by grafting a cellulose nanomaterial with acrylamide monomers wherein the cellulose nanomaterial is CNC and CNF.
- hydrophilic or amphiphilic polymeric network composed of monomers derived from acrylamide, CNC and CNF, wherein each of the monomers is crosslinked to another monomer to provide a covalently-associated polymeric network.
- the material of the invention is typically a three-dimensional polymeric structure that is substantially insoluble in water.
- the material is nevertheless capable of absorbing and retaining large amounts of water and may thus be characterized as hydrogel.
- the material refers both to a hydrogel in the hydrated state (when it contains water when formed in an aqueous solution, or after hydration) and to a dry hydrogel (when it has been formed in a non-aqueous medium or when it has been dried) containing residual amounts of water, e.g., up to 1% (by weight) or no water at all.
- the hydrogel When in a dry form, or in any form capable of absorbing other or additional materials, the hydrogel may absorb a material to be contained or entrapped therein. Typically, entrapment of a material(s) occurs within pores present in the hydrogel.
- the pores may be of non-uniform or uniform diameters (for example in the nm or micrometric range). In some embodiments, the pores are non-uniform in diameter and may be of diameter between 0.2 and 2 microns. The amount of water or any other material may be absorbed or permeated into the hydrogel, thus acting as a sorbent material.
- a hydrogel comprising or consisting of a cellulose nanomaterial grafted with acrylamide, wherein the cellulose material consisting cellulose nano crystals (CNC) and cellulose nano fibers (CNF).
- the hydrogel is capable of absorbing at least 10 % by weight of water.
- at least 10% of the hydrogel weight is water.
- the water content (by weight relative to the total weight of the hydrogel) is 10, 15, 20, 25, 30, 35, 40, 45 or 50%. In some embodiments, the water content is greater than 50%.
- the hydrogel upon hydration, the hydrogel swelled to at least 100, 200, 300, 400, 500, 600, 700, 800, 900, 1000 % its dry form. In some embodiments, the hydrogel swelled to between 1000 and 2000 or 1000 and 1500 % of its dry form.
- the weight of the hydrated hydrogel is 7 to 10 times its dry weight.
- CNC and CNF are fibers produced from cellulose.
- Cellulose is composed of linear chains of 1-4 D-glucose, arranged in an ordered fibril structure, which is comprised of ordered crystalline regions linked together by less ordered amorphous areas.
- Cellulose may be degraded using mechanical shearing methods to CNF, which are comprised of both the crystalline and amorphous regions of the fiber, resulting in particles which are 10-40 nm in width and span several microns in length and may be further degraded, e.g., by acid hydrolysis, to yield the crystalline regions alone, known as CNC.
- CNC fibers are 5-10 nm in width and a few micrometers in length, depending on the cellulose source.
- each of the CNC and CNF may have or comprise one or more glucose ring units that undergoes radical ring opening.
- each of the terms acrylamide unit”, CNC unit' and CNF unit' means a component of the polymeric material that is derived from acrylamide, CNC and CNF, respectively, following a chemical reaction as disclosed herein.
- the acrylamide unit is derived from acrylamide and thus in a polymer of the invention may have the structure , wherein each of the dashed lines designates a bond connecting to other units of the polymeric material.
- CNC and CNF being different in lengths and structural compositions, similarly contain a plurality of sugar units of the structure .
- the CNC unit and CNF unit in a polymer of the invention may be of the form the dashed lines designates a bond connecting the sugar units and wherein the bond extending to AA designates a bond associating to a unit derived from acrylamide (AA).
- a polymeric material of the invention generally has a structure of a polyacrylamide that is grafted or formed in the presence of CNC and CNF molecules.
- the polymeric material of the invention may be structurally depicted as ed lines designates a bond connecting the other sugar units of the CNC and/or CNF and to other acrylamide units of the material.
- the mechanical and rheological properties of polymers of the invention are superior to those observed in other similar systems. Surprisingly, this may be so due to the structural difference existing between the CNC and CNF. While CNF chains are of greater lengths as compared to chains of CNC, and their inherent flexibility act as strong backbones, enabling acrylamide chains to propagate to form a strongly interconnected fiber, the CNC chains act as small crosslinking joints, which enable efficient crosslinking. Putting it is believed that CNF acts as the main load-baring component which grants the impressive mechanical properties observed for the resulting hydrogels, while CNC also grants some mechanical strength, but mainly contributes to a homogenous dispersion while still being compatible with the system.
- CNC (probably due to its colloidal stability and smaller size) enables the integration of relatively high loadings of CNF to form better homogenous structures that are capable of impressive mechanical performance. The contribution of CNC in aiding CNFs' integration is evident by the rheological measurements shown and discussed below.
- grafted' or any lingual variation thereof refers to covalently attaching acrylamide monomers to the CNC and CNF backbones, which polymerize, to produce a grafted polymer of polyacrylamide, CNC and CNF.
- the grafted polymer chains making up the material of the invention may be further crosslinked to each other by using a bridging material such as N,N’ -methylene bisacrylamide (BAM) to form a uniform chemical network of long flexible chains.
- BAM N,N’ -methylene bisacrylamide
- All polymeric materials of the invention are polyacrylamide grafted on a nanocellulose consisting of CNC and CNF, wherein the ratio between the acrylamide units to the nanocellulose units (CNC+CNF) and the ratio between the two nanocelluloses (CNC and CNF) may be varied in order to vary or modulate or improve one or more of mechanical, rheological and biocompatible properties of the final polymeric material.
- the ratio between the nanocellulose material (CNC and CNF combined) and the acrylamide used in processes of the invention may vary, wherein generally the amount of the acrylamide is greater than the amount of each and both nanocelluloses.
- the ratio between the two nanocelluloses (CNC and CNF combined) and acrylamide (designated NBA ratio) is between 1: 100 and 1:5 NCAA.
- the amount of the acrylamide may at least 5 times and at most 100 times greater than the amount of the nanocelluloses combined.
- the NCAA ratio is 1: 100, 1:90, 1:80, 1:70, 1:60, 1:50, 1:40, 1 :30, 1:20, 1: 15, 1: 10 or 1:5.
- the ratio between the CNC and the CNF may also vary.
- the amount of the CNC may be increased relative to the amount of CNF in order to increase dispersibility and shear-thinning properties, leading to better homogeneity of the pre-polymerized solution. Higher amounts of CNC relative to NFC lead to increased stretchability and resilience.
- the ratio amount of CNC to CNF may be between 100: 1 and 10: 1.
- the ratio CNCCNF is 100: 1, 90: 1, 80: 1, 70: 1, 60: 1, 50: 1, 40: 1, 30: 1, 20: 1, or 10: 1.
- the ratio is 5: 1, 4: 1, 3: 1 or 2: 1 CNCCNF.
- CNF amounts may be increased relative to CNC.
- the ratio amount of CNF to CNC may be between 100: 1 and 10: 1.
- the ratio CNF:CNC is 100:1, 90: 1, 80: 1, 70: 1, 60: 1, 50: 1, 40: 1, 30: 1, 20: 1, or 10: 1.
- the ratio is 5: 1, 4: 1, 3: 1 or 2: 1 CNF:CNC.
- the ratio CNC to CNF may vary between 1: 100 to 100: 1 CNCCNF. In some embodiments, the ratio is between 5: 1 and 1:5 CNCCNF.
- a material of the invention comprising acrylamide units, CNC units and CNF units, or in a material formed by metal-mediated radical copolymerization of acrylamide, CNC and CNF, having a ratio FIFA of between 1: 100 and 1:5, the CNC: CNF ratio is between l: 10 to 10: 1 CNCCNF.
- a material of the invention comprising acrylamide units, CNC units and CNF units, or in a material formed by metal-mediated radical copolymerization of acrylamide, CNC and CNF, wherein the CNC:CNF ratio is between l: 10 to 10: 1 CNC:CNF, the ratio NCAA is between 1: 100 and 1:5.
- the nanocelluloses are provided at a ratio amount NC: A A of between 1: 100 and 1:5, and the CNCCNF ratio is any one of between 1 : 100 to 100: 1; between 1: 10 to 10: 1; between 1:5 and 5: 1; between 100: 1 and 10: 1; between 1: 100 and 1:5; 1: 100; 1:90; 1:80; 1:70; 1:60; 1:50; 1:40; 1:30; 1:20; 1: 10; 1:5; 100: 1; 90: 1; 80: 1; 70: 1; 60: 1; 50: 1; 40: 1; 30: 1; 20: 1; 10: 1; 5: 1; 4: 1; 3: 1; or 2: 1 CNCCNF.
- the invention further provides a process for manufacturing a material of the invention, the process comprising reacting a combination of CNC and CNF, at a predetermined CNC: CNF ratio, in presence of acrylamide under conditions allowing radical grafting and polymerization of the CNC, CNF and acrylamide.
- the process comprises treating a mixture of CNC, CNF and acrylamide, optionally in the presence of N,N’ -methylene bisacrylamide (MBA), and under conditions permitting co-polymerization.
- MBA N,N’ -methylene bisacrylamide
- the process comprises forming a mixture of CNC and CNF at a desired ratio, wherein the mixture is formed by homogenization, e.g., by sonication.
- the homogenized CNC and CNF mixture is treated with acrylamide and optionally with MBA and thereafter treated with a metal ion precursor, such as a metal salt or a metal complex, optionally a cerium metal salt or complex, e.g., cerium(iv) ammonium nitrate ([NH4]2[Ce(NO3)6], CAN), or Fe 2+ salts in the presence of hydrogen peroxide, under conditions permitting polymerization between the monomeric units (e.g., the acryl units, CNC units and CNF units, as defined) in the mixture.
- a metal ion precursor such as a metal salt or a metal complex, optionally a cerium metal salt or complex, e.g., cerium(iv) ammonium nitrate ([NH4]2[Ce(NO3)6], CAN), or Fe 2+ salts in the presence of hydrogen peroxide, under conditions permitting polymerization between the monomeric units (e.g., the acryl units, CNC units and CNF units,
- Polymeric materials of the invention may be used as hydrogels.
- the hydrogels may be provided in a variety of forms, including beads, solid matrixes, blocks, sheets or may be provided as shaped objects of any form.
- the hydrogels may be useful in a variety of applications and may thus contain one or more additional active or non-active components.
- the materials are highly biocompatible with a living tissue and provide advantageous effects when positioned in contact with a subject’s tissue, e.g., within a subject’s body or topically on the subject’s skin or external tissues.
- the hydrogels may also be used as drug release platforms for controllably and effectively delivering drugs and other therapeutic or cosmetic agents to a subject’s tissue.
- the hydrogels may be used in vivo, ex vivo or in vitro for a variety of purposes, such as biomaterials, supplying a suitable environment for growth, viability and proliferation of live cells.
- Such cells may be derived from a variety of tissues such as lung, liver, kidney, thymus, thyroid, heart, brain, pancreas, and the like, and cultured cell populations.
- Non-limiting examples of cells include fibroblasts, human umbilical vein endothelial cells (HUVECs), chondrocytes and osteoblasts.
- a surprising feature of the hydrogel or matrix material is that the use of the hydrogel or matrix allows growing and proliferation of cells without the necessity of adding cell attachment promoting elements such as the RGD peptide.
- a biomaterial is also provided which is or comprises a hydrogel of the invention.
- the biomaterial may be used as a substrate for cells and tissue generation.
- the biomaterial may be used for forming a transplant for implanting in a mammal.
- the transplant may be configured for transplantation into the mammal.
- Transplants of the invention may be any implant that comprises a hydrogel of the invention and may be useful in inducing or improving therapeutic conditions benefiting from implantable delivery systems for biologically active and gene therapy products for the treatment of a variety of diseases or medical conditions.
- the hydrogel may be provided with cells to form a transplant for injection into a subject at a site where the transplant is intended to be placed. This allows a non-invasive transplantation method of cells.
- the hydrogel may be used as a matrix material for holding and delivering and biomaterials, including without limitation, cells secreting human nerve growth factors, satellite cells, striatal brain tissue, liver cells, bone marrow cells, dopamine-rich brain tissue and cells, cholinergic-rich nervous system cells, adrenal chromaffin cells, cultured epithelium, and cells releasing ciliary neurotropic factors, blood cells, hepatocytes, pancreatic tissue, hemopoietic stem cells, bone marrow, Leydig cells, thyroid cells, pituitary cells, cardiac cells, renal cells and others as disclosed herein (including specific examples of cells such as fibroblasts, human umbilical vein endothelial cells (HUVECs), chondrocytes and osteoblasts).
- biomaterials including without limitation, cells secreting human nerve growth factors, satellite cells, striatal brain tissue, liver cells, bone marrow cells, dopamine-rich brain tissue and cells, cholinergic-rich nervous system cells, adrenal chromaffin cells, cultured epi
- the hydrogel matrix of the invention may be used for long-term storage and proliferation of cellular tissues. Cells may be frozen in the hydrogel matrix without loss of viability.
- the invention further provides a transplant for implanting in a subject, the transplant comprising cells contained within and/or a surface region of a hydrogel according to the invention.
- Also provided is a method of protecting cells comprising adding or contacting or immersing a hydrogel of the invention in a cell culture medium and allowing the cells to be absorbed by the hydrogel.
- a cell delivery system comprising a hydrogel of the invention comprising a plurality of cells to be delivered or transplanted.
- a method for delivery of viable cells to a mammal comprising positioning a cell delivery system at a desired location for cell delivery to a mammal, the cell delivery system comprising a hydrogel according to the invention (used as the delivery system) and cells; wherein the hydrogel containing the cells inside pores formed therein and/or its surface.
- a device for releasing a material in a recipient subject, in vivo, ex vivo or in vitro comprising a matrix containing the material and having a porosity permitting passage therethrough of the material.
- hydrogels of the invention may be loaded to contain (or made to absorb) an active material, a biological sample, a solution, or any material whatsoever by any means suitable in the art.
- the hydrogel may be immersed in a solution containing the material to be absorbed or precursors thereof.
- the hydrogel may be treated under pressure conditions to cause effective absorbance of the material.
- the hydrogel may be treated by, e.g., plasma spray or other deposition means to cause the hydrogel to at least partially absorb the material. Surface coating of the hydrogel may also occur.
- the material may be selected from any of the materials disclosed herein and also amongst active ingredients, diagnostic materials, drugs, coloring materials, amino acids, nucleic acids, peptides, polymers, taggant materials, biomaterials, cells, biological or chemical media, disinfectants, antioxidants, minerals, biominerals, and others.
- the material is selected from hydroxyapatite (HA), cells such as fibroblasts, human umbilical vein endothelial cells (HUVECs), chondrocytes and osteoblasts; and other active materials.
- HA hydroxyapatite
- cells such as fibroblasts, human umbilical vein endothelial cells (HUVECs), chondrocytes and osteoblasts; and other active materials.
- hydrogels of the invention may be generally utilized in:
- the invention further provides a method of modulating mechanical or rheological properties of a hydrogel formed of CNF grafted with acrylamide monomers, the method comprising:
- the invention further provides a method of modulating mechanical or rheological properties of a hydrogel formed of CNC grafted with acrylamide monomers, the method comprising:
- the expression 'modulating mechanical or rheological properties refers to increasing or decreasing, enhancing or diminishing at least one mechanical or rheological property selected from resilience; elasticity; tensile strength; toughness; compressive strength; extensibility; stretchability; pore size; surface texture or surface roughness; hardness; and Young’s modulus.
- the improvement is the hydrogel stretchability and resilience.
- the improvement is the hydrogel toughness.
- the invention further provides a medical device or an implant comprising or consisting of a hydrogel of the invention.
- the invention further provides:
- a material comprising or consisting a cellulose nanomaterial grafted with acrylamide, wherein the cellulose material consisting a mixture of cellulose nano crystals (CNC) and cellulose nano fibers (CNF).
- CNC cellulose nano crystals
- CNF cellulose nano fibers
- the material is in a form of a matrix material comprising or consisting a polymeric material comprising units of acrylamide, cellulose nano crystals (CNC) and cellulose nano fibers (CNF), wherein said units are polymerized therebetween to provide the matrix material.
- a matrix material comprising or consisting a polymeric material comprising units of acrylamide, cellulose nano crystals (CNC) and cellulose nano fibers (CNF), wherein said units are polymerized therebetween to provide the matrix material.
- the material is formed by grafting the cellulose nanomaterial with acrylamide monomers.
- the material is a hydrogel in a hydrated or dry hydrogel form.
- the material is in a dry form and the hydrogel is capable of absorbing at least 10 % by weight water. In some embodiments of any of the materials disclosed herein, the material is in the hydrated form and the hydrogel having a weight that is 7 to 10 times its dry weight.
- the material is in a form of beads, blocks, sheets or an amorphous form.
- the material comprising at least one active or non-active material.
- the material is biocompatible with a living tissue.
- the material is for delivery of an active material to a living tissue in vivo or ex vivo.
- the material is configured for positioning in contact with a tissue in a subject’s body or topically on a subject’s skin.
- the material is for use as a drug release platform for controllably and effectively delivering the drug to a subject’s tissue.
- the material is for causing proliferation of live cells in vivo.
- the cells are fibroblasts.
- the material is for use in a method of manufacturing a medical device or an implant.
- the material is used as an implant that is selected from synthetic heart valves, vascular grafts, cartilage and bone grafts, tendons and ligaments, soft tissue replacement materials, tissue replacement materials, and fibers.
- the material is for use in a method of manufacturing a material delivery device for delivery of a therapeutic or a cosmetic agent in vivo or in vitro.
- a process for manufacturing a hydrogel material comprising or consisting a cellulose nanomaterial grafted with acrylamide, wherein the cellulose material consisting a mixture of cellulose nano crystals (CNC) and cellulose nano fibers (CNF), the process comprising reacting a combination of CNC and CNF, at a predetermined CNC:CNF ratio, in presence of acrylamide or grafted acrylamide under conditions causing radical grafting and polymerization ⁇ )f the CNC, CNF and acrylamide.
- CNC cellulose nano crystals
- CNF cellulose nano fibers
- the ratio CNC:CNF is between 1: 100 to 100: 1.
- the ratio CNC:CNF is between 100: 1 and 10: 1.
- the ratio CNC:CNF is between 5: 1 and 1:5.
- the ratio CNC:CNF is 100: 1, 90: 1, 80: 1, 70: 1, 60: 1, 53: 1, 40: 1, 30: 1, 20: 1, or 10: 1.
- CNC:CNF is 5: 1, 4: 1, 3: 1 or 2: 1.
- the CNC, CNF and acrylamide are provided at a ratio CNC and CNF, combined, to acrylamide (CNC+CNF:acrylamide) of between 1: 100 and 1:5.
- the ratio CNC+CNF: acrylamide is between 1: 100 and 1:5, and wherein the ratio CNC:CNF is between 1: 10 to 10: 1.
- the ratio CNC+CNF: acrylamide is 1: 100, 1:90, 1:80, 1:70, 1:60, 1:50, 1:40, 1:30, 1:20, 1: 15, l: 10 or 1:5.
- the method is for increasing the hydrogel toughness, wherein the ratio CNF: CNC is between 100: 1 and 10: 1.
- the method is for increasing the hydrogel toughness, wherein the ratio CNF:CNC is 100: 1, 90: 1, 80: 1, 70: 1, 60: 1, 50: 1, 40: 1, 30: 1, 20: 1, or 10: 1.
- the method is for increasing the hydrogel toughness, wherein the ratio CNF:CNC is 5: 1, 4: 1, 3: 1 or 2: 1.
- the method is for increasing hydrogel stretchability and resilience, wherein the ratio CNC:CNF is between 100: 1 and 10: 1. In some embodiments of any of the methods disclosed herein, the method is for increasing hydrogel stretchability and resilience, wherein the ratio CNC:CNF is 100: 1, 90: 1, 80: 1, 70: 1, 60: 1, 50: 1, 40: 1, 30: 1, 20: 1, or 10: 1.
- the method is for increasing hydrogel stretchability and resilience, wherein the ratio CNC:CNF, is 5: 1, 4: 1, 3: 1 or 2: 1.
- the method comprising treating a mixture of CNC, CNF and acrylamide with N,N’ -methylene bisacrylamide (MBA).
- the method comprising forming a mixture of CNC and CNF at a CNC: CNF ratio, wherein the mixture is formed by homogenization.
- the method comprising homogenizing a CNC and CNF mixture and treating same with acrylamide and MBA, followed by addition of a metal ion precursor.
- the metal ion precursor is a metal salt or a metal complex.
- the metal ion precursor is a cerium metal salt or complex.
- he cerium metal salt is cerium(iv) ammonium nitrate ([NH4]2[Ce(NO3)6], CAN).
- a process for modulating a mechanical or a rheological property of a hydrogel formed of CNF grafted with acrylamide monomers comprising:
- a process for modulating a mechanical or a rheological property of a hydrogel formed of CNC grafted with acrylamide monomers comprising:
- the modulating a mechanical or a rheological property comprises improving the hydrogel stretchability and resilience.
- the modulating a mechanical or a rheological property comprises improving the hydrogel toughness.
- a hydrogel comprising or consisting a material as disclosed herein as a matrix material.
- the hydrogel comprising an active or a non-active material.
- the hydrogel is for use as a drug release platform for controllably and effectively delivering a drug to a subject’s tissue.
- the hydrogel is for supplying live cells to a tissue.
- the hydrogel is for use in a method of forming a wound dressing, a shock absorbing material, or an energy storage device.
- a medical device formed of a hydrogel according to the invention is a medical device formed of a hydrogel according to the invention.
- An implant formed of a hydrogel according to the invention is an implant formed of a hydrogel according to the invention.
- the hydrogel is for use or preparation of an implant selected from synthetic heart valves, vascular grafts, cartilage and bone grafts, tendons and ligaments, soft tissue replacement materials, tissue replacement materials, and fibers.
- a substrate for tissue engineering for growing cells and tissues in vivo or in vitro the substrate being formed of or comprising a material according to any the invention.
- a biomaterial formed of, or being, or comprising a material according to the invention may comprise a mineral, e.g., hydroxyapatite.
- biomineralized material being or comprising a material according to the invention, wherein optionally the biomineralized material comprises hydroxyapatite.
- the biomineralized material may further comprise at least one active ingredient or cells, as disclosed herein.
- Fig. 1 provides a depiction of a CNC/CNF grafted with acrylamide.
- Fig. 2 is an illustrated overview of a fabricated hydrogel and its opacity in variable compositions.
- C1F0 fabricated with the addition of CNC alone
- C0F1 fabricated with the addition of CNF alone
- C3F1, C1F1 and C1F3 fabricated with CNC and CNF at 3: l, 1: 1 and 1:3, respectively.
- Figs. 3A-E demonstrate mechanical properties (tensile) of fabricated cellulose- based hydrogels.
- A Tensile stress-strain curves,
- B elongation at break,
- C ultimate tensile stress UTS,
- D toughness and
- E Young’s modulus of different hydrogels fabricated with variable composition of CNC and CNF.
- Figs. 4A-E demonstrate cyclic tensile loading. Cyclic tensile tests of different fabricated hydrogel samples namely (A) C1F3, (B) C3F1, (C) C1F1, (D) C0F1 and (E) C1F0, with CNC and CNF in variable compositions.
- Fig. 5 demonstrates viscosity as a function of shear rate for pre-polymerized solutions with varying ratios between CNC and CNF before polymerization.
- Figs. 6A-B provide rheological measurements of the fabricated hydrogels composites represented in loss modulus G" and storage modulus G' with respect to frequency for samples C1F0 and C0F1 (A) and C1F3, C1F1, C3F1 (B).
- Figs. 7A-E provide rheological measurements of the fabricated hydrogels composites represented in loss modulus G" and storage modulus G' with respect to amplitude for different fabricated hydrogel samples namely (A) C1F3, (B) C1F1, (C) C3F1, (D) C1F0 and (E) C0F1, with CNC and CNF in variable compositions.
- Figs. 8A-B show swelling and degradation profiles of fabricated hydrogels in physiological conditions of pH 7.4.
- Figs. 9A-D provide cytocompatibility of CNC-CNF and acrylamide-based hydrogels with mouse fibroblasts, 3T3s (transfected with GFP).
- A Confocal micrographs taken after culturing 3T3s-GFP onto the hydrogels for a week. The images are representative images of overlapped z-sections.
- B Confocal image for sample C1F3 represented in 3D view depicting the depth coverage by the cells.
- Fig. 10 depicts representative compressive properties of fabricated hydrogel compositions.
- Fig. 11 depicts representative compressive properties of fabricated hydrogel compositions with different MBA content.
- Figs. 12A-B depict proliferation and cytotoxicity of endothelial cells cultured onto the fabricated hydrogels as determined by MTT assay (A) and under confocal microscopy (B).
- FIGs. 13A-C depict sterilization method comparison.
- A Relative cellular metabolic activity evaluated by alamarBlue at set time intervals of 1-, 7-, 14- and 21- days post cell-seeding for samples sterilized by EtOH, Autoclave and EtO.
- B Comparison of sterilization methods on cellular growth on sample C1F1.
- C confocal microscope images of (GFP) transfected mouse fibroblasts (3T3s) on the seeded C1F1 scaffolds following different sterilization techniques. Scale bar 100 pm.
- Fig. 14 provides sterilization method comparison. Relative cellular metabolic activity evaluated by alamarBlue at set time intervals of 1-, 7-, 14- and 21 -days post cell-seeding for samples sterilized by EtOH and y-irradiation.
- Figs. 15A-B provide a representative tensile (A) and compressive (B) properties of sun-, UV-, and heat-induced polymerization.
- Figs. 16A-C provide a representation of biomineralized samples.
- A comparison between an unmineralized (left) and mineralized (right) samples.
- B Biomineralized sample cut in half showing HA penetration and distribution.
- C Representative compressive of Biomineralized samples.
- Figs. 17A-D provide Cryo-SEM and EDS-mapping of biomineralized samples.
- A Cryo-SEM, 5K magnification scale bar 1 pm.
- B Cryo-SEM, 10K magnification, scale bar 1 pm.
- C Visual representation of sections I, II and III evaluated for EDS under SEM, scale bar 200 pm.
- D Visual representation of sections I, II and III evaluated for EDS, scale bar 1 mm.
- the table provides EDS elemental distribution of carbon (C), oxygen (0), calcium (Ca) and phosphorus (P) withing the three designated sections within the hydrogel.
- Figs. 18A-B demonstrate: Fig. 18A- Pre-polymerized samples with increased cerium content. From left to right lx (control), 2x, lOx and 50x CAN content. Fig. 18B- a lOx CAN polymerized sample- resulting in a soft, pasty, and easy to break matrix.
- Fig. 19 provides representative tensile tests of increased CNP content samples.
- Cellulose nanocrystals were supplied by Melodea Ltd. (Rehovot, Israel); cellulose nanofibrils were supplied by Cellulose Lab (Fredericton, New Brunswick, Canada).
- Acrylamide (AM), N,N’ -methylene bisacrylamide (MBA), cerium(IV) ammonium nitrate ([NH4]2[Ce(NO3)6],CAN), calcium chloride (CaCh), and dipotassium hydrogen phosphate (K2HPO4) were purchased from Sigma-Aldrich.
- Hydrochloric acid (HC1) was purchased from Romical (Beer Sheva, Israel).
- Hydrogels were fabricated based on cerium-initiated graft copolymerization by using ceric ions to initiate polymerization of acrylamide grafted from the cellulose particle backbone.
- CNC:CNF mixture suspensions were prepared by mixing CNC and CNF suspensions (3 wt% each) at 1:3, 1 : 1, and 3: 1 (wt/wt) CNC to CNF and homogenized by sonication using a Q500 ultrasonic processor (Qsonica, Newtown, CT, USA) at 80% amplitude 1 s on/1 s off pulse regime for a total of 30 min.
- the CNC:CNF solutions were then diluted to 1.6 wt% with AM (0.07 mol) and MBA (0.03 mmol) to a total volume of 20 mL.
- an initiator solution was prepared by dissolving CAN (0.036 mmol) in 5 mL double distilled water and adjusting the pH to 1 using 1 M HC1. The initiator solution was added dropwise to the cellulose -acrylamide mixture by stirring and poured into molds. Polymerization occurred at 55 °C for 12 hr. Fabricated hydrogels were carefully removed for further testing.
- compositions were labeled according to their CNC to CNF content ratio, and categorized, namely C1F3 (1:3), C1F1 (1: 1), C3F1(3: 1), C1F0 (1:0), and C0F1 (0: 1), where C and F represent CNC and CNF, respectively.
- Samples were immersed in All samples were immersed in phosphate buffer saline (PBS, (150 mM NaCl, 2.5 mM KC1, 10 mM K2HPO4, 2 mM KH2PO4, pH7.4) until reaching equilibrium prior to testing.
- PBS phosphate buffer saline
- UTS ultimate tensile stress
- Frequency sweeps were preformed from 0.1 to 100 Hz at a fixed strain of 1%, and the storage (G’) and loss (G”) moduli were recorded. Amplitude sweeps were performed at a constant 1.33Hz, at a sheer strain (y(%)) in ranges between 0.1 and 100%. The linear viscoelastic region (EVER), yield point (xy), flow point (if) and the flow transition index (rf/ry) have been calculated in all samples.
- Degradation of the samples was determined by incubating the samples in PBS for 6 weeks with regular change of PBS and calculating the dry weight of the samples once per week. Prior to weighing each sample was washed using DI water to remove excess salts from the material. Both experimentations were performed in triplicates.
- Green fluorescent protein (GFP) transfected mouse fibroblasts (3T3s) were generously donated by Professor Dr. Sharon Elizur-Schlesinger (The Hebrew University of Jerusalem). Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing L-glutamine, glucose, sodium pyruvate, and sodium bicarbonate. Media was supplemented with fetal bovine serum to a final concentration of 10 % and antibiotics i.e., penicillin (10 Units/mL) and streptomycin (10 pg/mL) to minimize possible contamination. The cells were maintained in a humidified environment of a sterile cell culture incubator maintained with 5 % carbon dioxide at 37 °C. The media of the cultured cells was regularly changed, and cells were passaged after achieving 70 % confluency.
- DMEM Dulbecco's Modified Eagle's Medium
- the hydrogels were sterilized with 70 % ethanol before cell seeding.
- the fabricated hydrogels were incubated in 70 % ethanol for 30 min and irradiated with UV simultaneously in a sterile cell culture hood.
- Samples were subsequently washed thrice with sterile phosphate buffer saline (PBS, calcium, and magnesium free, pH 7.4) with a 20 min incubation in each wash to remove any traces of ethanol.
- samples were acclimatized with DMEM media overnight. The media was removed, and hydrogels were dried for 4 hours in a sterile cell culture incubator before adding the cells to enhance the efficiency of static cell seeding (5x l0 4 cells/hydrogel) onto the porous hydrogel.
- Proliferation and morphology of the cells onto the fabricated hydrogels was evaluated using a confocal microscope. As the 3T3s were transfected with GFP, no additional staining was conducted. A week post cell seeding, the cell laden hydrogels were fixed with 4 % paraformaldehyde, washed thrice with PBS for 10 min each and observed under a confocal microscope (exact specifications will be added). The area covered (%) by the cells with respect to the total area in each hydrogel composition was calculated by ImageJ using the confocal images obtained post culturing the cells for a week. Cellular migration was measured for composition C1F3 through the 3D view observed in confocal microscopy.
- Cellular proliferation and viability were determined for the cell laden hydrogels by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay that calculates the metabolic activity of the cells and provides an indicator for cellular viability.
- MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- the procedure followed for the assay was as per the manufacturer’s protocol.
- the hydrogels were transferred to fresh wells to avoid any reading from cells that were not attached to the hydrogels. These cell laden hydrogels were then incubated in MTT dye for 4 h.
- the purple-colored product formed upon the reduction of MTT dye by cellular oxidoreductase is dissolved in dimethyl sulfoxide (DMSO), and the colorimetric reading was obtained in a spectrophotometer (exact specifications will be added) at 595 nm.
- DMSO dimethyl sulfoxide
- Human umbilical vein endothelial cells were grown in endothelial cell growth medium supplemented with fetal calf serum (0.02 mL/mL), epidermal growth factor (5 ng/mL), basic fibroblast growth factor (10 ng/mL), insulin-like growth factor (20 ng/mL), vascular endothelial growth factor (0.5 ng/mL), ascorbic acid 1 pg/mL, heparin 22.5 pg/mL and hydrocortisone 0.2 pg/mL.
- HUVECs were cultured in sterile humidified environment of cell culture incubator maintained at 37 °C and 5 % carbon dioxide.
- a preliminary in vitro screening with human endothelial cells was conducted.
- the proliferation and viability test by 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay was carried out as per the manufacturer’s protocol.
- MTT 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide
- the cell laden hydrogels were transferred to fresh wells to avoid any reading from the unattached cells and incubated in MTT dye for 4 h.
- the purple-colored product formed upon the reduction of MTT dye by cellular oxidoreductase is dissolved in dimethyl sulfoxide (DMSO) and the colorimetric reading was obtained in a spectrophotometer at 595 nm.
- DMSO dimethyl sulfoxide
- HUVECs cultured on the hydrogels for 2 weeks was observed by staining the F-actin filaments and nuclei with high-affinity phalloidin conjugated to tetramethyl rhodamine (TRITC) dye (Actin-555) and 4',6-diamidino-2- phenylindole (DAPI), respectively as per the manufacturer’s protocol.
- TRITC tetramethyl rhodamine
- DAPI 4',6-diamidino-2- phenylindole
- Green fluorescent protein (GFP) transfected mouse fibroblasts (3T3s) were donated by Professor Dr. Sharon Elizur-Schlesinger (The Hebrew University of Jerusalem). Cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing L-glutamine, glucose, sodium pyruvate, and sodium bicarbonate. Media was supplemented with fetal bovine serum to a final concentration of 10 % and antibiotics i.e., penicillin (10 Units/mL) and streptomycin (10 pg/mL) to minimize possible contamination. The cells were maintained in a humidified environment of a sterile cell culture incubator maintained with 5 % carbon dioxide at 37 °C. The media of the cultured cells was regularly changed, and cells were passaged after achieving 70 % confluency.
- DMEM Dulbecco's Modified Eagle's Medium
- EtOH ethanol
- EtO ethylene oxide
- Sterilization by y-radiation was performed by irradiation at 40°C with an average dose of 28 kGy and a nominal dose rate 7 kGy/h. 60Co gamma-ray source was used. Sterilization was carried out by Sor-Van Ltd. Soreq, Yavne, Israel.
- Proliferation and morphology of the cells on the fabricated hydrogels was evaluated using a confocal microscope. Imaging was performed using a Leica DMI8 Stellaris 5 STED confocal system (Leica, Wetzlar, Germany) with the LAS X life science software (LAS X 4.4.0.24861; Leica, Wetzlar, Germany). 21 days post cell seeding, the cell-laden hydrogels were fixed with 4% paraformaldehyde (PFA), washed thrice with PBS for 10 min, and imaged.
- PFA paraformaldehyde
- Composite hydrogels were fabricated by redox-initiated free radical graft polymerization of AM and cellulose-derived particles.
- grafting of the AM onto the particles’ surface was initiated using Ce 4+ as an oxidizer, which generates free radicals form the surface of the cellulose-derived particle, leading simultaneously to the formation of grafted cellulose particles and to the propagation of polyacrylamide (PAAM) chains from dissolved AM monomers.
- PAAM polyacrylamide
- Propagating chains are then further crosslinked with BAM, which led to the formation of the uniform hydrogels.
- the resulting hydrogels ranged from completely transparent when integrating CNC alone (C1F0) to completely opaque when comprised of CNF only (C0F1) (Fig. 2).
- composites fabricated with the integration of CNF alone namely C0F1 resulted in a hard and non-uniform gel, displaying a three-fold increase in young’s modulus, recorded at 307 kPa, and a high UTS of 390 kPa, but extend by only 105 %, the lowest value recorded.
- these cellulose-derived particles differ in aspect ratio, rheological properties, and colloidal stability, these results demonstrate the manner of which the addition of either of these particles, using this proposed grafting system, may affect the range of mechanical performance achievable by these types of composites.
- Samples comprised of CNC:CNF mixtures seem to benefit from each of the cellulose- based components.
- CNC displays strong colloidal stability and shear-thinning properties, which aid in creating a homogeneous dispersion aiding in the formation of a uniform network.
- CNF possesses higher aspect ratio (i.e., particle length) which grant increased mechanical performance, but tend to clump together and aggregate, leading to non-uniform densities throughout the network and increased viscosity which hinder processing and the loss of the nano-dimensional properties of the material.
- C1F0 (Fig. 4) begins with expressing high resilience, 91.5 %, at 200 % extension, but experience a large decrease upon reaching their maximum recorded extension of 1000 % of 10.3 %, down to 82.2 %- pointing to material fatigue over the course of repeating extension cycles at increasing strains.
- C0F1 (Fig. 4E) exhibits the lowest resilience recorded at 200 % extension, reaching 87.3 %.
- Viscosity as a function of shear rate was performed to quantify the viscous behavior of the different solutions when incorporating varying ratios between CNC and CNF.
- cellulose-derived nanoparticles generally and CNC specifically possess known shear-thinning properties, it was expected that by optimizing an effective mixture between CNC and CNF a reduction in overall viscosity will be achieved compared to CNF mixtures.
- Reduced viscosity may aid in the homogenization, handling and future molding of the pre-polymerized solutions and the homogeneity of resulting samples- leading to consistent mechanical performance and sample reproducibility.
- Fig. 5 a reduction in viscosity occurred in all samples as shear rates increased.
- Samples C1F1 and C3F1 express similar viscosities to C1F0, showing the ability to incorporate CNF without compromising the solution’s viscosity, allowing effective mixture and dispersion, and resulting in homogeneous samples upon polymerization.
- the flow transition index which is derived from the values calculated above, points to the area in which the LVER has passed but the amount of deformation has yet to arrive at a critical point where the micro-structure begins to crack, where G”> G’. It can be determined that C0F1 (Fig. 7E) shows the poorest structural integrity, expressing the lowest flow transition index measured at 10. C1F0 (Fig. 7D) on the other hand shows a relatively high flow transition index of 59.9. This may show that by employing CNC the material is able to withstand a higher amount of deformation, possibly due to the small size of the CNC particles, which act as efficient, small crosslinking joints, acting as stress recovery mechanisms. C1F3 (Fig. 7A) and C1F1 (Fig.
- hydrogels may affect their mechanical performance and aid in determining the material’s potential applications and roles.
- PBS at physiological pH was chosen as a swelling buffer. All compositions tested retain their original shape indefinitely when submerged in excess PBS without dissolving or rupturing, implying a strong crosslinked network.
- C1F0 samples swell the most, swelling to 1150 % their original weight over a 5-day period.
- C0F1 samples swell the least, reaching 750 % their original weight over a 5-day period, possibly pointing to increased network density resulting from the longer, fibrillated CNF particles.
- the swelling properties of CNC:CNF blends then generally relate to the ratio of its constituents- increased CNC ratio leads to increased swelling ratio, as can be seen in sample C3F1 while increased CNF ratio leads to a decrease in swelling capabilities (Fig. 8A). Furthermore, Samples which incorporate higher loadings of CNF reach their swelling equilibrium faster, as can be seen in samples C0F1 and C1F3, equilibrating after 10-15 hours as opposed to samples with higher CNC content, C1F0 and C3F1, which reach equilibration after 60 hours.
- hydrogels are intended to function in aqueous environments or, more importantly, in biologically active environments such as the human body, and may become exposed to several degrading factors. Thus, it is important to determine possible degradation of the material. Degradation may lead to residual material circulating in the body, which if uncontrolled may lead to undesired effect such as clotting, creating blockage and inflammation. Results suggests most tested samples closely keep their original weight (>95 %) throughout the 6-week period evaluated. Composites fabricated by the incorporation of CNF alone, C0F1, lost some weight (-10 %) following the first week tested, which may result from sample inhomogeneity, leading to un-crosslinked residues leeching out of the sample (Fig. 8B). Biocompatibility and cytotoxicity studies
- Preliminary screening of the fabricated hydrogels for their potential as a biomaterial was conducted by evaluating their cytocompatibility and toxicity with mammalian fibroblasts.
- the GFP transfected 3T3s (GFP-3T3s) were statically seeded on the hydrogels, while media was added to the wells containing the hydrogels after an hour to allow time for maximum cellular adhesion. It is vital for any biomaterial to be non-toxic and biocompatible.
- a preliminary evaluation of CNC, CNF, CNC: CNF blends and a control group comprised of acrylamide alone without the addition of cellulose-derived nanoparticles (AM) was conducted.
- Hydrogels seeded with the GFP- 3T3s cells indicate that all samples fabricated with the addition of the cellulose-derived nanoparticles support the adhesion and proliferation of mammalian cells, as can be seen in the confocal microscope images (Fig. 9A).
- MTT analysis indicated a significant difference for cellular adhesion in all hydrogels when compared with the control AM hydrogel. No significant difference was observed amongst the test samples (C1F1, C3F1 and C1F3) for cellular adhesion as observed on day 1 post cell seeding, indicating that all hydrogels fabricated based on mixtures of CNC and CNF exhibit similar properties suitable for cell adhesion (Fig. 9B).
- sample C1F3 shows significant growth of cells as compared to C1F1 and C3F1 (Fig. 9B).
- CNF appears to contribute to cellular proliferation compared to the addition of CNC, which is indicated by a significant difference in cellular growth when comparing samples C0F1 and C1F0 following incubation for 7 days (Fig. 9B).
- the area covered by the fibroblasts calculated from the confocal images also reveals that C1F3 has significantly higher cell coverage compared to samples C1F1 and C3F1 (Fig. 9C).
- Morphological observations reveal that sample C1F3 exhibits a more uniform cellular growth and deeper cell migration ( ⁇ 80 pm) with wide-spread spindle shaped morphology (Fig.
- Fig. 10 presents typical stress-strain curves obtained by compressing samples to 50 % their original height over 4 loading-unloading cycles.
- the calculated compressive properties are shown in Table 4. All sample composed with various loadings of CNC evaluated (C1F3, C1F1, C3F1, and C1F0) express impressive resilient properties (>90%) and, following a first conditioning cycle, are able to withstand repeated deformation cycles with negligible hysteresis. Sample C0F1, prepared with the addition of CNF alone, expresses a significant reduction in resilience, calculated at an average of 79.4%, possibly due to reduced sample homogeneity.
- HUVECs observed on this hydrogel composition exhibit characteristic three-dimensional tubular network, characteristic of endothelial cells, indicating an optimal environment for their sustainable growth with intercellular interactions. All hydrogels appear to promote improved cellular adhesion and growth as compared to samples composed of acrylamide alone (AM). The ability of these hydrogels to promote the growth of HUVECs and supporting the aforementioned tubular structures without the need of any additional growth factors or cellular adhesion motifs emphasizes the potential of the fabricated hydrogels as potential scaffolds for tissue engineering.
- sun- and UV-polymerized samples were expressing roughly half the UCS of the heat-polymerized samples, measured at 23, 20 and 42 kPa respectively, yet retaining excellent resilience, measured at 93.2% for both light-polymerized samples.
- sun- and UV- polymerized samples could stretch roughly half the length of the heat-polymerized samples before breaking and expressed a third of the UTS, measured at 32, 33.2 and 92.7 kPa respectively.
- C1F0 samples were prepared as mentioned above (General methods, hydrogel fabrication). Biomineralization hydroxyapatite onto the scaffold template was performed by immersing samples in alternating solutions of calcium (CaCh) and phosphate (K2HPO4). As such, hydrogel samples were immersed in solutions composed of 250 mmol/L CaCh (27.75 mg/ml) and 150 mmol/L K2HPO4 (26.13 mg/ml) in alternating cycles, 24 hr. at a time for 8 consecutive days, beginning with sonication (30 min, 01/01, 25%) to facilitate solution penetration.
- CaCh calcium
- K2HPO4 phosphate
- Integrating macro-sized reinforcing filaments was tested as means to strengthen the tensile properties of the hydrogel.
- Both sample the gauze and viscose filaments were treated with consecutive washes of acetone, NaOH (0.2M) and HC1 (0.2M), and DDW in that order, to remove any residual substances and dried.
- Hydrogels were cast on a polystyrene plate along with a control without the addition of any filaments to ensure a successful reaction. After casting samples were placed in an oven at 55°C for 12 hr.
- the metal salt e.g., cerium ammonium nitrate (CAN)
- CAN cerium ammonium nitrate
- CNPs cellulose nano particles
- CNC CNC or CNF
- CAN cellulose nano particles
- Each CAN concentration was cast in 3 1 ml repeats- 2 samples with cotton fibers, and the other without, as a control evaluating the respective CAN concentration’s effect on the polymerization progress.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Composite Materials (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Graft Or Block Polymers (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363480182P | 2023-01-17 | 2023-01-17 | |
| PCT/IL2024/050054 WO2024154120A1 (en) | 2023-01-17 | 2024-01-15 | Hydrogels and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4651915A1 true EP4651915A1 (en) | 2025-11-26 |
Family
ID=89723056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24702207.2A Pending EP4651915A1 (en) | 2023-01-17 | 2024-01-15 | Hydrogels and uses thereof |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4651915A1 (en) |
| WO (1) | WO2024154120A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107325470A (en) * | 2017-07-12 | 2017-11-07 | 浙江大学 | A kind of cellulose nano-fibrous enhancing phenyl boric acid based aquagel and preparation method thereof |
| CN110172127B (en) * | 2019-05-27 | 2022-03-01 | 天津市木精灵生物科技有限公司 | Nano cellulose based plugging agent and preparation method thereof |
-
2024
- 2024-01-15 WO PCT/IL2024/050054 patent/WO2024154120A1/en not_active Ceased
- 2024-01-15 EP EP24702207.2A patent/EP4651915A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024154120A1 (en) | 2024-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shuai et al. | Accelerated degradation of HAP/PLLA bone scaffold by PGA blending facilitates bioactivity and osteoconductivity | |
| Boyer et al. | Laponite nanoparticle-associated silated hydroxypropylmethyl cellulose as an injectable reinforced interpenetrating network hydrogel for cartilage tissue engineering | |
| Suneetha et al. | Bone-like apatite formation in biocompatible phosphate-crosslinked bacterial cellulose-based hydrogels for bone tissue engineering applications | |
| Huang et al. | Biofabrication of natural Au/bacterial cellulose hydrogel for bone tissue regeneration via in-situ fermentation | |
| Khan et al. | Bioactive scaffold (sodium alginate)-g-(nHAp@ SiO2@ GO) for bone tissue engineering | |
| Kaviani et al. | Conductive GelMA/alginate/polypyrrole/graphene hydrogel as a potential scaffold for cardiac tissue engineering; physiochemical, mechanical, and biological evaluations | |
| Gao et al. | Polydopamine-templated hydroxyapatite reinforced polycaprolactone composite nanofibers with enhanced cytocompatibility and osteogenesis for bone tissue engineering | |
| Khor et al. | Implantable applications of chitin and chitosan | |
| Depan et al. | Organic/inorganic hybrid network structure nanocomposite scaffolds based on grafted chitosan for tissue engineering | |
| Tabatabaee et al. | Fabrication and characterization of PHEMA–gelatin scaffold enriched with graphene oxide for bone tissue engineering | |
| Zheng et al. | Modification of 3-D porous hydroxyapatite/thermoplastic polyurethane composite scaffolds for reinforcing interfacial adhesion by polydopamine surface coating | |
| Nasiri et al. | Gelatin/PVP/hydroxyapatite nanocomposite based on double micro-emulsion for tissue engineering applications | |
| Cui et al. | Preparation, characterization, and biocompatibility evaluation of poly (Nɛ-acryloyl-l-lysine)/hyaluronic acid interpenetrating network hydrogels | |
| KR102364168B1 (en) | Scaffolds for bone regeneration and method for producing the same | |
| JP7836798B2 (en) | Preparation and application of biocompatible injectable and in-situ gelling hydrogels and cellulose nanofibril-based biocompatible injectable and in-situ gelling hydrogels for tissue and organ repair. | |
| Wan et al. | Investigation of mechanical properties and degradability of multi-channel chitosan–polycaprolactone/collagen conduits | |
| Deshpande et al. | Silk based bio–inks for medical applications | |
| Shokrollahi et al. | Biological and mechanical properties of novel composites based on supramolecular polycaprolactone and functionalized hydroxyapatite | |
| Li et al. | Fast gelling and non-swellable photopolymerized poly (vinyl alcohol) hydrogels with high strength | |
| Zhang et al. | Enzyme-Mineralized PVASA hydrogels with combined toughness and strength for bone tissue engineering | |
| Keaswejjareansuk et al. | Degradable alginate hydrogel microfiber for cell-encapsulation based on alginate lyase loaded nanoparticles | |
| Serrano-Aroca et al. | Acrylic-Based Materials for Biomedical and Bioengineering | |
| Adarsh et al. | Functionally graded bioactive composites based on poly (vinyl alcohol) made through thiol–ene click reaction | |
| Prebeg et al. | Hybrid hydrogels for bioink development and potential use in dental tissue engineering | |
| EP4651915A1 (en) | Hydrogels and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20250701 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) |